newsfilter
← Latest News
GlobeNewswire·

Orchard Therapeutics Announces Multiple Presentations at ESGCT 2023

Eight presentations highlight the differentiated profile and broad applicability of the company's HSC gene therapy platform Data from proof-of-concept study of OTL-203 in MPS-IH demonstrate favorable outcomes for